Ultragenyx Pharmaceutical Inc
SWB:UP0
Ultragenyx Pharmaceutical Inc
SWB:UP0
Price:
21.24
EUR
1.19%
Market Cap:
€2.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
U
|
Ultragenyx Pharmaceutical Inc
SWB:UP0
|
US |
|
V
|
Vale SA
XBER:CVLC
|
BR |
|
K
|
Klaveness Combination Carriers ASA
OSE:KCC
|
NO |
|
L
|
Lloyds Banking Group PLC
BMV:LYGN
|
UK |
|
CSL Ltd
F:CSJA
|
AU |
|
B
|
BAE Systems PLC
DUS:BSP
|
UK |
|
Yamaha Motor Co Ltd
F:YMA
|
JP |
|
P
|
Porr AG
DUS:ABS2
|
AT |
|
A
|
Auckland International Airport Ltd
F:BZTA
|
NZ |
Wall St Price Targets
UP0 Price Targets Summary
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc
Wall Street analysts forecast UP0 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for UP0 is 44.08 EUR with a low forecast of 21.26 EUR and a high forecast of 74.28 EUR.
Lowest Forecast
Price Target
21.26
EUR
0% Upside
Average Forecast
Price Target
44.08
EUR
108% Upside
Highest Forecast
Price Target
74.28
EUR
250% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UP0's stock price target?
Price Target
44.08
EUR
44.08
EUR
According to Wall Street analysts, the average 1-year price target for UP0 is 44.08 EUR with a low forecast of 21.26 EUR and a high forecast of 74.28 EUR.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
